In 2030, the transformative potential of weight-loss drugs, particularly GLP-1 agonists like semaglutide (Ozempic/Wegovy), could yield global health and economic…
Browsing: Clinical Updates
New tools in gastrointestinal bleeding (GIB) management, including hemostatic powders, capsule endoscopy, endoscopic clips, and over-the-scope devices, offer targeted approaches…
A study from the University of Pennsylvania, presented at the 2024 Digestive Disease Week (DDW), found that GLP-1 receptor agonists…
Exact Sciences unveiled data on the Cologuard Plus™ test at the American College of Gastroenterology (ACG) 2024 Annual Meeting, showcasing…
To mark Nature Reviews Gastroenterology & Hepatology’s 20th anniversary, experts discussed the microbiome’s impact on biology, the field’s current strengths…
OpenBiome, a nonprofit supplying fecal microbiota transplantation (FMT) material, announced a voluntary suspension of its distribution this week, affecting many…
The recent multisociety clinical practice document provides guidance on the perioperative management of GLP-1 receptor agonists (GLP-1RAs), emphasizing shared decision-making…
A recent study by WovenX Health showcased the potential of on-demand telehealth in cutting emergency department (ED) visits and associated…
A recent study published in Clinical Gastroenterology and Hepatology suggests that individuals with no detectable fecal hemoglobin (f-Hb) in prior…
IBD clinical trials face growing challenges with recruitment and design. Patients often opt for approved therapies over trials with placebo…